Table 2:
Reported extracorporeal membrane oxygenation support in spontaneously breathing patients
Year | Author [reference] | Number of patients | Bridging time [median (days)] | Diagnosis (number of patients) | Outcome |
---|---|---|---|---|---|
2008 | Broomé et al. [15] | 1 | 54 | Dermatomyositis | Alive |
2008 | Schmid et al. [16] | 1 | 62 | Pulmonary hypertension | Alive |
2010 | Garcia et al. [17] | 1 | 19 | COPD | Alive |
2010 | Nosotti et al. [5] | 1 | 2 | Pulmonary fibrosis | Alive |
2010 | Mangi et al. [18] | 1 | 3 | Pulmonary fibrosis | Alive |
2011 | Haneya et al. [19] | 2 | 70 | Pulmonary hypertension, cystic fibrosis | Alive |
2011 | de Perrot et al. [20] | 3 | 30 | Pulmonary hypertension | 2 alive, 1 dead after LTx |
2012 | Reeb et al. [21] | 1 | 11 | Cystic fibrosis | Alive |
2012 | Fuehner et al. [8] | 26 | 9 | Cystic fibrosis (5), pulmonary fibrosis (10), pulmonary hypertension (7), BOS (3), sarcoidosis (1) | 16 alive, 4 dead after LTx, 6 dead before LTx |
COPD: chronic obstructive pulmonary disease; BOS: bronchiolitis obliterans syndrome; LTx: lung transplantation.